FDA Investigator Brandon M Kurjanowicz
Brandon M Kurjanowicz has conducted inspections on 115 sites in 3 countries as of 10 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
115
Last Inspection Date:
10 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada,
Portugal
FDA Investigators that have inspected at least one site in common with Brandon M Kurjanowicz:
Adriana N Jimenez Lopez,
Alan D Centi,
Althea A Williams,
Amanda B Athey,
Anne E Johnson,
Brandon J Brookens,
Brian M Palermo,
Cara M Minelli,
Carl E Lovrich,
Carrie L Doupnik,
Cary Greene,
Chamberlain,
Christine I Shaw,
Christopher R Richardson,
Crayton Lee,
Cynthia L Rakestraw,
Daniel J Mechenbier,
Daniel R Tammariello,
Dauksism,
Dennis R Hock,
Dessa A Antoine,
Devon Jenkins,
Doreen P Gubbay,
Edward D Mcdonald,
Edward P Potter,
Eric L Vangraafeiland,
Eric Rothschild,
Eric S Myskowski,
Erica L Nicoll,
Gary C Pecic, Jr,
Gladys B Casper,
Greg Phillips,
Gregory E Beichner,
Heath A Gerber,
Iqra Iftikhar,
James M Odonnell,
James P Mcevoy,
Jamie D Richardson,
Jessica M Monteiro,
Joseph R Hatcher,
Joshua E Yao,
Justin B Holder,
Karen A Spencer,
Katelyn Astaub Zamperini,
Kirk A Dymbrowski,
LCDR William H Bender,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Marea K Harmon,
Margaret M Sands,
Marjorie L Davis,
Mary E Storch,
Mary R Kirker,
Maureen A Wentzel,
Melissa M Schafer,
Meredith L Sheridan,
Michael J Diskin,
Michael R Klapal,
Michele M Falchek,
Nisha C Patel,
Ramanda C Gregory,
Raymond L Cheung,
Russell J Glapion,
Sarah J Park,
Seng Ching Hwang,
Shelley L Waring,
Siobhan G Taylor,
Tammy M Phillips,
Thomas R Withers,
Todd J Maushart,
Tracynda L Davis,
Travis R Hunt,
Tressa T Lewis,
Van Cliff,
William A Warnick
Brandon M Kurjanowicz's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2014 | FDA 483 | Cima Technology Inc - Form 483, 2014-10-07 |
April, 2018 | FDA 483 | NutraStar, Inc. - Form 483, 2018-04-24 |
April, 2018 | EIR | NutraStar, Inc. - EIR, 2018-04-24 |
September, 2021 | EIR | J.M. Smucker LLC - EIR, 2021-09-30 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more